Please login to the form below

Mistura Informatics Pharmacist Donates Medicines Information Software to Tackle COVID-19

Mistura Informatics are donating their medicines information Software to the NHS for free to reduce pressure on NHS frontline staff during the COVID-19 crisis.

North East based Mistura Informatics is offering MaPPs (Medicines: A Patient Profile Summary), their online resource that provides up-to-date medicine information to the NHS for free, to reduce pressure on frontline staff during this time of national crisis.

Developed by former NHS pharmacist and company founder Dawn Price, MaPPs is an online resource that provides a simplified 300-word patient information summary on over 6,000 medicines available in the UK. MaPPs’ aims to help patients take their medication more effectively by providing an easy to understand explanation about their medicine, how to take it and any warnings or possible adverse side effects to look out for.

The MaPPs system can also be used to automatically generate MRCs (Medicine Reminder Charts) which enable patients to track their medicines with a clear schedule of how and when to take them. There are also MARs (Medicines Administration Records) for carers to record when medicines have been given.

MaPPs is currently installed in over 100 organisations including hospital trusts, pharmacies and Clinical Commissioning Groups (CCG’s), with a further 14 brought on board since the service has been made available free-of-charge.

At a time when NHS resources are under pressure, alternative staff are being deployed to face the unparalleled challenges of a global health pandemic, quickly discharging patients with the best possible medicine’s information couldn’t be more important. If a patient takes their medicine correctly, it reduces the risk of readmission due to non-compliance or adverse side effects.

Managing Director, Dawn Price said:“As the COVID-19 outbreak continues to ramp up pressure on the NHS, frontline staff will become increasingly time-poor. When every minute counts, MaPPs reduces the time spent explaining medicines to patients, making the hospital discharge service faster and more efficient.

Safeguarding patient’s wellbeing is paramount during this crisis. Our software will give people the tools to take their medication safely and effectively with a clear written record.”

A pilot exercise conducted with Surrey and Sussex Healthcare NHS Trust found that 93% of responders understood the purpose of their new medication and its possible side effects two weeks after being discharged with a MaPPs leaflet. The patient’s understanding of their medication also increased, which improved overall discharge experience.

Mistura will be happy to assist further NHS organisations looking to implement MaPPs during the COVID-19 outbreak.

For further information contact Dr Dawn Price on 07732 623547 or dawn.price@misturainformatics.org

8th April 2020

Share

Tags

Company Details

ahair@onyxhealth.com

Website

Address:
Generator Studios, Trafalgar Street
Walker Road
Newcastle Upon Tyne
England
NE1 2LA
United Kingdom

Latest content on this profile

Onyx Health Announces Two Top Appointments
Onyx health have made two senior appointments to their communications team
ahair@onyxhealth.com
Onyx Health Marks Record Growth with Six New Appointments
Onyx Health has expanded its communications team with six new appointments, after more than doubling its fee incomes and expanding its international client portfolio over the past year
ahair@onyxhealth.com
Onyx Health Launch Creative Studio After Record Year
Healthcare marketing communications specialists Onyx Health have set up a new creative studio following a year of record income growth and international client expansion.
ahair@onyxhealth.com
PulmoBioMed Wins National Life Science Competition
Newly launched Northumbria University spinout PulmoBioMed has been handpicked as the winners of Onyx Health's ThinkBig competition
ahair@onyxhealth.com
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
Leading biotechnology company NovaBiotics Ltd have secured a major licensing deal for their fungal nail treatment
ahair@onyxhealth.com
Newcells Biotech secures over £5m for 3D tissue models
Newcells Biotech have received multi-million investment to develop their pioneering 3D tissue models
ahair@onyxhealth.com